1. Home
  2. EOLS vs GCBC Comparison

EOLS vs GCBC Comparison

Compare EOLS & GCBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • GCBC
  • Stock Information
  • Founded
  • EOLS 2012
  • GCBC 1889
  • Country
  • EOLS United States
  • GCBC United States
  • Employees
  • EOLS N/A
  • GCBC N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • GCBC Banks
  • Sector
  • EOLS Health Care
  • GCBC Finance
  • Exchange
  • EOLS Nasdaq
  • GCBC Nasdaq
  • Market Cap
  • EOLS 412.0M
  • GCBC 391.6M
  • IPO Year
  • EOLS 2018
  • GCBC 1998
  • Fundamental
  • Price
  • EOLS $6.73
  • GCBC $23.75
  • Analyst Decision
  • EOLS Strong Buy
  • GCBC
  • Analyst Count
  • EOLS 5
  • GCBC 0
  • Target Price
  • EOLS $21.25
  • GCBC N/A
  • AVG Volume (30 Days)
  • EOLS 2.3M
  • GCBC 15.3K
  • Earning Date
  • EOLS 08-05-2025
  • GCBC 07-23-2025
  • Dividend Yield
  • EOLS N/A
  • GCBC 1.52%
  • EPS Growth
  • EOLS N/A
  • GCBC 26.12
  • EPS
  • EOLS N/A
  • GCBC 1.83
  • Revenue
  • EOLS $277,941,000.00
  • GCBC $74,038,000.00
  • Revenue This Year
  • EOLS $33.42
  • GCBC N/A
  • Revenue Next Year
  • EOLS $33.18
  • GCBC N/A
  • P/E Ratio
  • EOLS N/A
  • GCBC $12.99
  • Revenue Growth
  • EOLS 17.15
  • GCBC 15.47
  • 52 Week Low
  • EOLS $5.71
  • GCBC $20.00
  • 52 Week High
  • EOLS $17.82
  • GCBC $35.34
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 33.84
  • GCBC 48.06
  • Support Level
  • EOLS $6.21
  • GCBC $22.58
  • Resistance Level
  • EOLS $6.74
  • GCBC $25.00
  • Average True Range (ATR)
  • EOLS 0.45
  • GCBC 0.76
  • MACD
  • EOLS -0.16
  • GCBC -0.01
  • Stochastic Oscillator
  • EOLS 27.49
  • GCBC 46.61

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About GCBC Greene County Bancorp Inc.

Greene County Bancorp Inc is a holding firm. Its primary business involves overseeing and directing the business of The Bank of Greene County and monitoring its cash position. Through its directly and indirectly owned subsidiaries, the company engages in attracting retail deposits, along with funds generated from operations and borrowings, predominantly in one to four-family residential mortgage loans, commercial real estate mortgage loans, consumer loans, home equity loans, and commercial business loans. It also serves local municipalities' banking needs and operates a real estate investment trust.

Share on Social Networks: